BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 32160908)

  • 21. MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance.
    Salguero I; Belotserkovskaya R; Coates J; Sczaniecka-Clift M; Demir M; Jhujh S; Wilson MD; Jackson SP
    Nat Commun; 2019 Nov; 10(1):5191. PubMed ID: 31729360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-homologous DNA end joining and alternative pathways to double-strand break repair.
    Chang HHY; Pannunzio NR; Adachi N; Lieber MR
    Nat Rev Mol Cell Biol; 2017 Aug; 18(8):495-506. PubMed ID: 28512351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
    Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
    Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation.
    Bakr A; Oing C; Köcher S; Borgmann K; Dornreiter I; Petersen C; Dikomey E; Mansour WY
    Nucleic Acids Res; 2015 Mar; 43(6):3154-66. PubMed ID: 25753674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters.
    Loughery J; Cox M; Smith LM; Meek DW
    Nucleic Acids Res; 2014 Jul; 42(12):7666-80. PubMed ID: 24928858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Landscape of genomic alterations in cervical carcinomas.
    Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
    Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
    Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D
    Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular response to DNA damage: a focus on MDC1 and its interacting proteins.
    Coster G; Goldberg M
    Nucleus; 2010; 1(2):166-78. PubMed ID: 21326949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDC1: The art of keeping things in focus.
    Jungmichel S; Stucki M
    Chromosoma; 2010 Aug; 119(4):337-49. PubMed ID: 20224865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.
    Moody CA; Laimins LA
    PLoS Pathog; 2009 Oct; 5(10):e1000605. PubMed ID: 19798429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage.
    Chapman JR; Jackson SP
    EMBO Rep; 2008 Aug; 9(8):795-801. PubMed ID: 18583988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
    Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
    Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.
    Nakanishi M; Ozaki T; Yamamoto H; Hanamoto T; Kikuchi H; Furuya K; Asaka M; Delia D; Nakagawara A
    J Biol Chem; 2007 Aug; 282(31):22993-3004. PubMed ID: 17535811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes.
    Stucki M; Jackson SP
    DNA Repair (Amst); 2006 May; 5(5):534-43. PubMed ID: 16531125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.
    Stucki M; Clapperton JA; Mohammad D; Yaffe MB; Smerdon SJ; Jackson SP
    Cell; 2005 Dec; 123(7):1213-26. PubMed ID: 16377563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.
    Lee JH; Paull TT
    Science; 2005 Apr; 308(5721):551-4. PubMed ID: 15790808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDC1 is a mediator of the mammalian DNA damage checkpoint.
    Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
    Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.